Title: Prognostic value of myocardial scar in ischaemic and non-ischaemic cardiomyopathy using cardiac magnetic resonance imaging
Authors: Reem Laymouna, Eman El-Sharkawy, Salah El-Tahan, Mohamed El-Fiky
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 132–139
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-040
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-040 Aim: The aim of this research
was to evaluate the prognostic value of
myocardial scar using cardiac magnetic resonance
(CMR) imaging in patients with ischaemic
cardiomyopathy (ICM) and non-ischaemic
cardiomyopathy (NICM). Methods: One hundred and
fifty-four patients with either ICM or NICM
underwent CMR with late gadolinium enhancement
sequences for assessment of left ventricular
ejection fraction (LVEF), and detection and
quantification of any myocardial scar using
three methods: manual, number of segments
involved, and percentage of scarred myocardium.
Patients were followed up for at least six
months for clinical cardiac events. Results: Patients were divided
into two groups: group I, patients with ICM
(58%) and group II, those with NICM (42%).
Clinical presentation ranged from eventless
(10%) to chest pain (18%), heart failure (15%),
hospitalisation (35%), syncope (1%), ventricular
tachycardia (< 1%) and cardiac arrest (< 1%).
The scar mass was larger in size in group I (17
± 15%) than in group II (8 ± 13%). A direct
relationship was observed between scar size and
event severity (p < 0.001). An inverse
relationship between LVEF and event severity was
found in group I (p < 0.001) but not in group II
(p = 0.128). Conclusion: Myocardial scar
size was a strong predictor of clinical outcome
in both the ICM and NICM patients. LVEF was less
reliable in predicting morbidity in
cardiomyopathy patients.
Title: Trends and outcomes of cardiovascular disease admissions in Lagos, Nigeria: a 16-year review
Authors: Amam C Mbakwem, Casmir Ezenwa Amadi, Jayne N Ajuluchukwu, Oyewole A Kushimo
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 140–148
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-037
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-037 Background: Cardiovascular
disease (CVD)-related admissions are on the
increase in Nigeria and the rest of Africa. This
study was carried out to highlight the burden,
patterns and outcomes of CVD admissions in a
tertiary hospital over a 16-year period in
Lagos, Nigeria. Methods: Admissions records of
patients admitted into the medical wards within
the study period (January 2002 to December 2017)
were reviewed and relevant information
pertaining to the study objectives was retrieved
for analysis. Results: There were a total of
21 369 medical admissions and 4 456 (20.8%)
CVD-related admissions. A total of 3 582 medical
deaths were recorded and 1 090 (30.4%)
CVD-related deaths. The median age of the
patients was 56.6 (46.0–68.0) years and 51.4% of
these were males. Stroke, heart failure,
hypertensive disease and acute coronary syndrome
constituted 51.2, 36.2, 11.3 and 1.6% of all CVD
admissions, respectively. There was a cumulative
increase in the number of CVD admissions and
deaths (p < 0.001, respectively) during the
period under review. Conclusion: CVD admissions are
not only common in Nigeria, but there was also a
temporal exponential increase in both the
admission and death rates, most likely
reflecting the epidemiological transition in
Nigeria.
Title: Clinical profile and outcomes of young patients treated with implantable cardioverter defibrillators at a South African tertiary hospital: a review of two decades of implantable cardioverter defibrillator implantation and follow up
Authors: Philasande Mkoko, Kayla Solomon, Ashley Chin
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 150–156
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-039
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-039 Aim: In young patients without
atherosclerotic coronary artery disease, the
aetiology of sudden cardiac death (SCD) has been
described in Europe and North America. However,
there are important regional variations and
there are limited data on the aetiology and
outcome of SCD in South Africa. The objective of
this study was to determine the profile and
outcomes of young patients treated with
implantable cardioverter defibrillators (ICDs)
at a South African tertiary hospital. Methods: This study was
designed as a retrospective review of patients
aged 35 years or younger implanted with ICDs at
Groote Schuur Hospital. Results: During the study
period, 38 patients younger than 35 years were
implanted with ICDs. The mean (standard
deviation) age at ICD implantation was 25.1
(7.6) years and 63.2% were male. A
secondary-prevention ICD was implanted in 57.9%
of the patient population, and primary
prevention in the remaining 42.1%. Patients with
secondary-prevention ICDs presented with
ventricular tachycardia (59.1%), ventricular
fibrillation (31.8%) and receipt of
cardiopulmonary resuscitation but no recorded
electrocardiograms (9.1%). Arrhythmogenic right
ventricular cardiomyopathy (ARVC) was the
leading cause of SCD in the secondary-prevention
patient population (36.4%). Idiopathic dilated
cardiomyopathy accounted for 50% of the
primary-prevention patient population. After a
median (interquartile range) follow up 32
(14–90) months, 7.9% died and 5.2% received a
heart transplant; 42.1% of the study population
received appropriate ICD shock therapies and
18.4% received inappropriate shock therapies. Conclusion: In this
single-centre study from South Africa, ARVC and
repaired congenital heart disease were the
leading causes of SCD in patients younger than
35 years treated with secondary-prevention ICDs.
Primary-prevention ICDs were frequently
implanted for idiopathic dilated cardiomyopathy.
Title: Prevalence and associated risk factors for elevated blood pressure in young adults in South Africa
Authors: Sanushka Naidoo, June Fabian, Shane A Norris
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 157–163
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-036
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-036 Background: Sub-Saharan Africa
has been shown to have a high prevalence of
hypertension (58% in rural black South Africans)
with an accelerated course ending in end-stage
renal disease. We sought to determine whether
the prevalence of elevated blood pressure (EBP)
in early adulthood was associated with any risk
factors and/or renal target-organ damage in
young adulthood, which could prevent development
of these cardiorenal sequelae. Methods: Data including risk
factors for hypertension and markers of kidney
damage were collected from young adults (n =
933; age 28 years; 52% female) participating in
the Birth to Twenty Plus (BT20) cohort in
Soweto, South Africa. Blood pressure was
measured on one occasion. Results: Fifty-four per cent of
the study sample had EBP with more men affected
(62%) than women (47%) (p < 0.001). Body mass
index (BMI), hyperuricaemia and albuminuria had
significant associations with EBP in men. In
women, BMI, hyperuricaemia and a self-reported
history of gestational hypertension had
significant associations. Conclusion: Our findings
suggest that the pathophysiology of EBP in young
adults differs between the genders and
highlights a number of modifiable factors in its
development.
Title: Creating blood conservation for a cardiothoracic surgical hospital: when you have to start from scratch!
Authors: Cenk Indelen, Yesim Uygun Kizmaz, Atakan Erkilinc, Adile Ece Altinay, Aryeh Shander, Mehmet Kaan Kirali
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 164–168
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-044
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-044 Background: This improvement
report presents a hospital blood-management
programme, a hospital-specific model that
differs from patient blood managment and was
aimed at improving operational standards of
transfusion. We identified the challenges of the
transfusion process and suggest practical
strategies for improving them. The aim of this
article was to investigate the effect of the
programme on the transfusion of blood
components. Methods: In January 2019, the
programme was started to improve the transfusion
process. The data before and after the start of
the programme were compared. Frequency
distribution was obtained for each variable for
statistical analysis and the chi-squared test
with continuity correction was used to compare
these variables for the years 2018 and 2019. Results: Transfusion of total
blood components decreased by 23.2%, fresh whole
blood by 46.7%, fresh frozen plasma by 38.4%,
pooled platelets by 14.0% and red blood cells by
9.66%. Autologous transfusion increased
11.7-fold. The emergency department (76.0%) and
intensive care unit transfusion rate (9.26%)
decreased significantly. Conclusion: This programme is
an example for hospitals where patient blood
management cannot be applied. The programme can
be considered the first step for blood
management and may be applied to blood
management in institutions worldwide. The
difficulty of blood supply and increased cost
will increase the importance of hospital
blood-management programmes in the coming years.
Title: Assessment of papillary muscle free strain in hypertrophic cardiomyopathy and hypertension-induced left ventricular hypertrophy
Authors: Cennet Yildiz, Atilla Koyuncu, Lutfi Ocal, Mustafa Ozan Gursoy, Ersan Oflar, Gokhan Kahveci
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 169–174
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-070
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-070 Objectives: We aimed to
evaluate and compare papillary muscle free
strain in hypertrophic cardiomyopathy (HCMP) and
hypertensive (HT) patients. Methods: Global longitudinal
strain (GLS), and longitudinal myocardial strain
of the anterolateral (ALPM) and posteromedial
papillary muscles (PMPM) were obtained in 46
HCMP and 50 HT patients. Results: Interventricular
septum (IVS)/posterior wall (PW) thickness
ratio, left ventricular mass index (LVMI), left
atrial anteroposterior diameter (LAAP) and
mitral E/E′ were found to be increased in
patients with HCMP compared to HT patients. Left
ventricular cavity dimensions were smaller in
HCMP patients. GLS of HCMP and HT patients were
–14.52 ± 3.01 and –16.85 ± 1.36%, respectively
(p < 0.001). Likewise, ALPM and PMPM free strain
values were significantly reduced in HCMP
patients over HT patients [–14.00% (–22 to –11%)
and –15.5% (–24.02 to –10.16%) vs –23.00%
(–24.99 to –19.01%) and –22.30% (–26.48 to
–15.95%) (p = 0.016 and p = 0.010)],
respectively. ALPM free strain showed a
statistically significant correlation with GLS,
maximal wall thickness, IVS thickness and LVMI.
PMPM free strain showed a significant
correlation with GLS, IVS thickness and LAAP.
The GLS value of –13.05 had a sensitivity of
61.9% and a specificity of 97.4% for predicting
HCMP. ALPM and PMPM free strain values of –15.31
and –17.17% had 63 and 76.9% sensitivity and
85.7 and 76.9% specificity for prediction of
HCMP. Conclusions: Besides other
echocardiographic variables, which were
investigated in earlier studies, papillary
muscle free strain also could be used in HCMP to
distinguish HCMP- from HT-associated
hypertrophy.
Title: Combined systolic velocities using tissue Doppler imaging could predict the severity of cirrhosis: a prospective cohort study
Authors: Ibrahim Dönmez, Emrah Acar
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 175–180
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2023-034
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2023-034 Aim: Recent research has
demonstrated that the contractile
characteristics of the right ventricular outflow
tract (RVOT) play a significant role in right
ventricular function. Pulmonary annular motion
velocity (PAMVUT) is a reliable marker of RVOT
function. Also, combined systolic velocity
[PAMVUT added to tricuspid annular systolic
velocity (St)] has been revealed as a suitable
parameter for right ventricular systolic
function. In this study, we examined the
association between the severity of the illness
in cirrhotic patients and the combined S
velocities (CSV). Methods: Seventy-four patients
with cirrhosis went to the echocardiography
laboratory of the Cardiology Department in our
centre. Traditional echocardiographic
measurements, PAMVUT and CSV values were
recorded. The Child–Pugh classes of the patients
were determined. Results: Receiver operating
characteristic curve analysis demonstrated that
a CSV of 23 cm/s constituted the cut-off value
for predicting a moderate-to-severe form of
cirrhosis with 76% sensitivity and 65.3%
specificity (area uder the curve = 0.735, p <
0.001). Conclusion: CSV values could
predict the severity of cirrhosis more precisely
than traditional right ventricular systolic
function parameters.
Title: Electric cardioversion in patients treated with oral anticoagulants: embolic material in the left atrial appendage
Authors: Jarosław Karwowski, Jerzy Rekosz, Mateusz Solecki, Renata Mączyńska-Mazuruk, Karol Wrzosek, Joanna Sumińska-Syska, Mirosław Dłużniewski
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 181–188
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-060
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-060 Abstract: Atrial fibrillation
(AF) remains the most common arrhythmia. The
sinus rhythm restoration procedure without
adequate anticoagulant preparation may lead to a
thromboembolic event in approximately 5–7% of
patients. The initiation of oral anticoagulation
significantly reduces this risk by inhibiting
formation of embolic material in the heart
cavities, especially in the left atrial
appendage (LAA). However, there is a group of
patients who develop embolic material in the LAA
despite oral anticoagulation treatment. The best
treatment method to dissolve thrombus in the LAA
is not clear, due to the lack of studies with
adequate power and endpoints that can determine
the best management strategy. We present
clinical trials comparing the efficacy and
safety of oral anticoagulants in patients
undergoing AF cardioversion. We evaluate the
frequency of LAA thrombus formation in patients
with AF on treatment with oral anticoagulants.
Furthermore, we discuss the effectiveness of
various treatment strategies on LAA thrombus
resolution.
Title: Permanent His bundle pacing using a Biotronik styletdriven lead: feasibility and early outcomes from a single centre
Authors: Brian Vezi, Ajijola Olujimi, Marcus Ngatcha, Aime Bonny, Justin Ragadu
From: Cardiovascular Journal of Africa, Vol 34,
Issue 3 July/August 2023
Pages: 190–194
Full text: Click here to order
»
Full text:
Click here to read online »
Full text: Click here to
read via Sabinet » (Login Required)
DOI Number: 10.5830/CVJA-2022-026
DOI Citation Reference Link:
dx.doi.org/10.5830/CVJA-2022-026 Abstract: His bundle pacing
(HBP) has been shown to be a good alternative to
conventional cardiac resynchronisation therapy
(CRT) and may theoretically provide an
additional benefit where CRT has a response
deficit of at least 30%. HBP requires mapping
and identification of the His bundle, and to
this purpose the lead delivery is challenging.
This first-reported case series from Africa
shares early experience with different pacing
indications (complete heart block and
pre-existing right ventricular pacing; heart
failure with left bundle branch block) for using
a standard 5.6F, Solia S 60, IS-1, ProMRI
bipolar pacing lead and an 8.7F Selectra 3D
introducer guide, 32–39-cm working length with
40/55/65-mm proximal radii (Biotronik). These
cases highlighted the importance of appropriate
programming when implanting HBP and of assessing
the conduction system to predict patients who
might benefit from HBP and additional left
ventricular lead implant. The Biotronik Solia
lead and delivery guide were found to be
feasible and reliable in these cases. The
Biotronik conduction system pacing tools were
used with good acute outcomes in patients with
different pacing indications.